A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

Clinical trial NCT00539344 · COMPLETED

Trial details

NCT number: NCT00539344
Sponsor: Angiochem Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent or Progressive Malignant Glioma

Start date: 2007-10-01
Primary completion: 2010-03-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.